Immunohistochemistry in Veterinary Diagnostics: Principles and Protocols

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-11

Key Takeaways

• Immunohistochemistry (IHC) relies on specific antibody-antigen binding to localize target proteins in tissue sections, crucial for confirming diagnoses, identifying neoplasm lineage, detecting infectious agents, and characterizing protein distribution in veterinary diagnostics.
• Proper tissue fixation (typically 10% neutral buffered formalin for 24-72 hours) and antigen retrieval (heat-induced or enzymatic) are critical for restoring epitope accessibility masked by fixation, with overfixation or strong acid decalcification leading to epitope destruction and false-negative results.
• Antibody selection requires validation for the target species and fixation method, considering the specificity of monoclonal versus the broader cross-reactivity of polyclonal antibodies, with cross-reactivity to human-derived antibodies being a significant concern in veterinary diagnostics.
• Blocking endogenous enzyme activity (peroxidase, alkaline phosphatase) and biotin is essential to prevent false-positive signals, with polymer-based detection systems offering an advantage by avoiding biotin-related background in tissues like liver and kidney.
• Every IHC run must include validated positive and negative tissue controls to ensure assay reliability; interpretation must always correlate staining patterns (nuclear, cytoplasmic, membranous) with morphology and known antigen distribution.
• Common failure modes include weak or absent signal due to fixation/retrieval issues, non-specific background from insufficient blocking or high antibody concentration, and false-positive signals from endogenous activity or cross-reactivity, all of which necessitate careful troubleshooting and control evaluation.

Immunohistochemistry (IHC) is a laboratory technique that localizes specific antigens in tissue sections through the binding of labelled antibodies. In veterinary diagnostics, IHC is used to confirm a histopathological diagnosis, identify the cell lineage of a neoplasm, detect infectious agents, and characterize the distribution of proteins within normal and diseased tissues. This article explains the underlying principles of the technique, the stepwise workflow from sample collection to microscopic evaluation, and the common sources of error that produce unreliable staining. It is written for veterinary students and practitioners who submit samples for IHC or interpret IHC reports and who need to understand what the technique can and cannot establish.

The article covers the scientific basis of antibody-antigen binding, the chemistry of detection systems, the practical decisions that determine staining quality, and a structured approach to troubleshooting failed or aberrant staining. Interpretation of specific tumor markers is excluded. The focus is cross-species, with attention to the differences in tissue handling and fixation that apply across domestic mammals, birds, and exotic species. The procedural emphasis means that the reader will finish with a working mental model of how a tissue sample becomes a stained slide and where in that chain of events artefacts are introduced.

At a Glance

Antibody-Antigen Binding and Specificity

IHC depends on the specificity of an antibody for its target epitope, the three-dimensional region of the antigen that the antibody recognizes. Polyclonal antibodies recognize multiple epitopes on the same antigen, which increases sensitivity but also the risk of cross-reactivity with unrelated proteins. Monoclonal antibodies recognize a single epitope, which improves specificity but makes the antibody more vulnerable to loss of that epitope during fixation or processing. The choice between these two formats is dictated by the target antigen, the species being examined, and the validation data available for the specific clone.

Cross-reactivity is a particular concern in veterinary samples because many commercial antibodies are raised against human antigens. A clone that works reliably on human tissue may fail on canine, feline, or equine tissue because of amino acid sequence differences in the epitope. Conversely, a clone may cross-react with an unintended protein that shares a homologous sequence. The Davis-Thompson Foundation veterinary pathology resources provide case material and teaching collections that illustrate the expected staining patterns of commonly used antibodies across species, which is a practical starting point for selecting a validated clone.

Fixation and Its Effects on Epitopes

Fixation preserves tissue morphology but chemically modifies proteins. Formalin cross-links amino groups, which masks many epitopes and prevents antibody access. The duration of fixation is therefore a critical variable. Underfixation leaves tissue poorly preserved and prone to autolysis, while overfixation creates excessive cross-linking that resists antigen retrieval. Most veterinary diagnostic laboratories recommend 10% neutral buffered formalin for 24 to 72 hours for routine IHC, but the optimal time varies with tissue thickness and the target antigen.

Decalcification is a second source of epitope damage. Strong acid decalcifiers such as nitric acid hydrolyse proteins and can abolish immunoreactivity entirely. EDTA-based decalcification is gentler and preserves more epitopes, but it is slower. When IHC is planned on bone or other mineralised tissue, the decalcification method must be chosen with the target antigen in mind. The MSD Veterinary Manual professional edition discusses specimen handling and the importance of proper fixation for histopathological evaluation, which applies directly to the quality of subsequent IHC.

Antigen Retrieval

Formalin fixation masks epitopes through methylene bridge formation between protein side chains. Antigen retrieval reverses some of this cross-linking and restores antibody access. Heat-induced epitope retrieval (HIER) is the most widely used method. Sections are heated in a buffer, typically citrate at pH 6.0 or EDTA at pH 8.0 to 9.0, using a pressure cooker, microwave, or water bath. The choice of buffer and pH depends on the target antigen and the antibody manufacturer's recommendations.

Proteolytic enzyme digestion is an alternative for a limited set of antigens, particularly some infectious agents and extracellular matrix proteins. Enzymatic retrieval uses pepsin, trypsin, or proteinase K and is performed at 37 degrees Celsius for a defined period. Overdigestion destroys tissue morphology and produces false-negative results, so the incubation time must be titrated for each tissue type. The optimal retrieval method for a given antibody is determined empirically and is usually stated in the antibody datasheet or in published validation studies.

Antibody Selection and Validation

Choosing the primary antibody is the first decision that determines whether the staining run will produce interpretable results. Antibodies validated for use in human tissue frequently cross-react with veterinary species, but cross-reactivity must be confirmed for each species and tissue type before diagnostic use. Commercial suppliers provide reactivity charts, yet these lists are not a substitute for in-house validation on control tissues from the species being tested.

Validation requires positive and negative control tissues processed identically to the patient sample. Positive controls should be selected from tissues known to express the target antigen at moderate levels, not from tissues with very high expression. A strongly positive control can mask suboptimal technique that would be evident with a moderately expressing tissue. Negative controls include both a tissue known not to express the target and a serial section of the patient sample incubated with an irrelevant antibody of the same isotype or with antibody diluent alone. This second control detects endogenous enzyme activity, biotin, or Fc receptor binding that could produce false positives.

Antibody clones differ in their sensitivity and specificity for the same antigen. A monoclonal antibody directed against a specific epitope may fail to recognize the homologous protein in a different species if the epitope differs by even a few amino acids. Polyclonal antibodies recognize multiple epitopes and often show broader cross-reactivity, but they carry a higher risk of off-target binding. The choice between monoclonal and polyclonal reagents depends on the target, the species, and the availability of validated clones. Reference laboratories and the Davis-Thompson Foundation veterinary pathology resources publish validated antibody panels and troubleshooting guidance that can inform reagent selection.

Blocking Steps and Endogenous Activity

Formalin-fixed tissues contain endogenous peroxidase, alkaline phosphatase, and biotin that can generate background signal indistinguishable from specific staining. Peroxidase is abundant in erythrocytes, granulocytes, and macrophages. Alkaline phosphatase is present in intestinal epithelium, kidney, and placenta. Biotin is concentrated in liver, kidney, and adipose tissue.

The choice of detection system determines which blocking steps are required. Peroxidase-based systems require incubation with hydrogen peroxide in methanol or buffer before the primary antibody. This step consumes endogenous peroxidase activity and prevents false brown staining. Alkaline phosphatase-based systems require levamisole in the substrate solution to inhibit endogenous alkaline phosphatase. Biotin-based amplification systems, such as avidin-biotin complex methods, require sequential avidin and biotin blocking steps to saturate endogenous biotin before the detection reagents are applied.

Blocking times and concentrations follow the manufacturer's recommendations, but the pathologist should verify that blocking does not damage the target epitope. Prolonged peroxide incubation can oxidise some antigens and reduce signal intensity. If the target is sensitive to peroxide, a non-biotin polymer detection system may be preferable because it avoids both the peroxide blocking step and the biotin blocking steps. Polymer systems use an enzyme-labelled polymer backbone that carries many antibody molecules, providing signal amplification without biotin.

Detection Systems and Chromogen Selection

Three detection systems dominate veterinary immunohistochemistry: avidin-biotin complex, labelled polymer, and tyramide signal amplification. Each has distinct performance characteriztics that matter in diagnostic settings.

The avidin-biotin complex method remains widely used because it is economical and produces strong signal. Its main weakness is background from endogenous biotin, which becomes problematic in liver, kidney, and tissues with necrosis. Labelled polymer systems avoid this problem entirely and are now the default choice in many laboratories. Tyramide amplification is reserved for antigens present at very low copy number, because its high sensitivity also amplifies any nonspecific binding.

Chromogen selection follows the detection enzyme. Diaminobenzidine produces a brown precipitate that is permanent, alcohol-resistant, and compatible with most counterstains. It is the standard choice for peroxidase systems. Aminoethylcarbazole gives a red product that is alcohol-soluble and requires aqueous mounting medium. Fast red and BCIP/NBT are used with alkaline phosphatase systems and produce red and blue-black precipitates respectively. The choice of chromogen should account for the counterstain and the presence of pigment in the tissue. Melanin, hemosiderin, and lipofuscin can obscure or mimic diaminobenzidine staining, and a red chromogen may be necessary to distinguish signal from brown endogenous pigment.

The Staining Protocol

A standard indirect immunohistochemistry protocol follows a fixed sequence. The steps below assume formalin-fixed, paraffin-embedded sections, which represent the majority of veterinary diagnostic samples.

1. Deparaffinise sections in xylene or a xylene substitute, then rehydrate through graded alcohols to distilled water.
2. Perform antigen retrieval according to the validated method for the target antibody. Heat-induced epitope retrieval in citrate buffer at pH 6.0 or Tris-EDTA at pH 9.0 is the most common approach. Enzymatic retrieval with proteinase K or pepsin is used for a minority of antigens.
3. Block endogenous peroxidase or alkaline phosphatase as required by the detection system.
4. Apply serum or protein block to reduce nonspecific antibody binding. The blocking serum should come from the species that produced the secondary antibody.
5. Incubate with primary antibody at the validated dilution and time. Typical incubations run 30 to 60 minutes at room temperature or overnight at 4 degrees Celsius. Overnight incubation often improves signal for difficult antigens but lengthens turnaround time.
6. Wash in buffer. The wash buffer, usually Tris-buffered saline or phosphate-buffered saline with Tween 20, removes unbound primary antibody.
7. Apply secondary antibody or polymer reagent and incubate for 30 minutes.
8. Wash again.
9. Apply chromogen and monitor color development under a microscope. Development times range from 2 to 15 minutes depending on the chromogen and the antigen abundance.
10. Stop the reaction in distilled water, counterstain with hematoxylin, dehydrate, clear, and mount.

Each step has a defined failure mode. Incomplete deparaffinisation produces patchy staining. Overcooked antigen retrieval destroys epitopes and produces weak signal. Insufficient retrieval leaves epitopes masked and produces false negatives. The troubleshooting table below lists the most common problems and their remedies.

Controls and Documentation

Every staining run must include a positive control, a negative control, and, where available, an internal positive control within the patient section. Internal controls are cells in the patient sample that normally express the target antigen. Their staining confirms that the procedure worked on that specific section. The absence of internal control staining when the target is expected in those cells invalidates the run.

Documentation should record the antibody clone, lot number, dilution, retrieval method, detection system, chromogen, and incubation conditions. This information allows the run to be reproduced and compared with previous runs. Digital images of the stained sections should be archived with the patient identifier and the staining parameters. The MSD Veterinary Manual and AVMA practice resources provide guidance on laboratory quality assurance and record keeping that applies to immunohistochemistry documentation.

Interpretation begins with the controls. If the positive control fails, the patient result is unreliable regardless of what the patient section shows. If the negative control shows staining, the detection system is producing nonspecific signal and the run must be repeated with adjusted blocking. Only after the controls are judged acceptable can the patient section be evaluated. The pathologist should assess staining location, intensity, and proportion of positive cells, and should compare the pattern with the known distribution of the target antigen in normal tissue.

Species differences affect antibody validation requirements. Antibodies validated in canine tissue may not perform identically in feline, equine, or bovine tissue. Each laboratory should validate antibodies for each species it tests, using positive and negative control tissues from that species. Cross-species validation is particularly important for production animals, where fixation and processing conditions may differ from those used in companion animal pathology.

Recognized Failure Modes and Early Detection

Immunohistochemistry fails through a limited set of recurring mechanisms. The most common is weak or absent signal, which usually traces to fixation, retrieval, or antibody performance. Overfixation in formalin beyond 48 to 72 hours progressively cross-links epitopes and resists routine heat-induced retrieval. Underfixation leaves tissue soft and prone to detachment during the staining run. Both states produce patchy or diffuse loss of signal that is first detected when the positive control tissue fails to stain in parallel.

Nonspecific background staining appears as diffuse brown or red signal over stroma, collagen, or necrotic areas. The usual causes are insufficient blocking of endogenous peroxidase or biotin, antibody concentration that is too high, or retrieval conditions that expose sticky hydrophobic residues. Background that spares the positive control but appears in test tissue points to tissue-specific factors such as necrosis, hemorrhage, or autolysis instead of a reagent problem.

False-positive signal is the most dangerous failure because it can drive an incorrect diagnosis. It arises from endogenous peroxidase in erythrocytes or granulocytes when hydrogen peroxide blocking is omitted, from biotin in liver or kidney when avidin-biotin detection is used without biotin blockade, and from cross-reactive antibodies binding to unrelated epitopes. The discriminating check is the negative control: if the negative control stains, the detection system or antibody is at fault, not the antigen.

Edge artifact, where staining concentrates at tissue margins, indicates drying of the section during the run or incomplete deparaffinization. Tissue detachment from the slide usually reflects poor adhesive coating, over-retrieval, or sections cut too thick. Both are detected during routine microscopic review and are corrected by adjusting the preanalytical steps.

Common Errors and Corrective Action

Less experienced operators most often err in the preanalytical phase. Submitting tissue in an inappropriate volume of formalin, usually less than 10 times the tissue volume, produces central autolysis that destroys epitopes before fixation reaches the core. The corrective action is to trim tissue to 3 to 5 mm thickness and confirm adequate fixative volume before submission. Decalcification in strong acids for prolonged periods degrades many antigens, if decalcification is required, the laboratory should be informed so that retrieval conditions can be adjusted.

A second frequent error is assuming that a validated antibody for one species will perform identically in another. Cross-reactivity is common for some antibodies and absent for others, and the optimal dilution often differs between species. The corrective action is to run a titration on known positive tissue from the target species before using the antibody diagnostically. The Davis-Thompson Foundation veterinary pathology resources provide case material and teaching collections that can serve as a source of positive control tissue across species.

A third error is interpreting the stain without reference to the H&E morphology. Immunohistochemistry is an adjunct to histopathology, not a substitute for it. A positive signal in a poorly preserved or incorrectly classified lesion can mislead. The corrective action is to evaluate the H&E first, define the question the IHC must answer, and then interpret the stain within that morphologic context.

Limitations of Current Evidence

The evidence base for veterinary immunohistochemistry is uneven. Antibody validation studies are published for common markers in dogs and cats, but many antibodies used in exotic species, birds, and production animals are validated only by cross-reactivity inference from other species. Expert opinion differs on whether cross-species use is acceptable when species-specific validation is unavailable. Some pathologists accept it with appropriate controls, others require validation in the target species before diagnostic use. This disagreement is genuine and unresolved.

Quantitative interpretation is also contested. Chromogenic IHC is at best semiquantitative, and thresholds for "positive" versus "negative" vary between laboratories. There is no universal scoring system for most veterinary markers, and interobserver agreement is imperfect. The MSD Veterinary Manual and the AVMA practice resources both emphasize that laboratory-specific protocols and interpretation criteria should be established and documented instead of assumed transferable.

Referral, Consultation, and Reporting

Referral to a veterinary anatomic pathologist is warranted when the stain result conflicts with the clinical picture, when the lesion is unusual, or when the diagnosis carries treatment or prognostic consequences that hinge on a single marker. A second opinion from a specialist laboratory is appropriate when the case involves a species with limited antibody validation, when the staining pattern is atypical, or when the referring clinician requests confirmation before major intervention.

Laboratory involvement should begin before the case becomes difficult. Confirm with the laboratory which antibodies are validated for the species and tissue in question, what fixation and decalcification constraints apply, and what controls will be run. Most laboratories provide submission guidelines that specify tissue size, fixative type, and acceptable fixation times. Following those guidelines prevents the majority of preanalytical failures.

Regulatory reporting applies when IHC results contribute to a notifiable disease diagnosis, particularly in production animals and wildlife. The WOAH terrestrial animal health standards define reporting obligations for listed diseases, and confirmation of a suspect case by a designated reference laboratory may be required before official notification. The attending veterinarian should verify the current reporting requirements for the relevant jurisdiction and species, as these obligations vary by country and disease.

Frequently Asked Questions

How much does immunohistochemistry cost, and how should I budget for it in practice?

Costs vary widely by laboratory, antibody, and tissue volume. A single IHC slide typically costs more than routine histopathology, and panels of three to five markers multiply that expense. For referral cases, request a written estimate before submission and confirm whether the laboratory charges for repeat stains or unstained sections. For in-house staining, the largest fixed costs are the primary antibodies, detection kits, and control tissues. Budget for validated positive and negative controls on every run, because a failed run without controls cannot be interpreted and will need to be repeated. Discuss cost expectations with the owner before sampling, and document the estimated charges in the medical record.

What can I do when the ideal equipment, such as a pressure cooker or automated stainer, is unavailable?

Manual staining with a microwave or a hot water bath can produce reliable results if the protocol is standardized. Use a thermometer to verify retrieval temperature instead of relying on timer settings alone. Keep retrieval times consistent and cool slides promptly to prevent over-retrieval. A humidity chamber made from a covered container with moistened paper towels prevents drying artefacts during incubation. Pipettes and a timer replace automated dispensers, but they demand stricter attention to reagent volumes and incubation times. If you lack a certified fume hood for chromogen handling, choose a less hazardous chromogen or send the staining to a referral laboratory. The Davis-Thompson Foundation veterinary pathology resources include practical guidance on adapting protocols to limited laboratory settings.

Does the staining protocol need to change for different species?

Yes. Antibodies validated for one species may cross-react poorly or not at all in another. A monoclonal antibody raised against human CD3 often works in dogs and cats, but cross-reactivity in ruminants, horses, or birds must be verified with positive control tissue from that species. Fixation times also differ with tissue type and size, and some species have higher levels of endogenous peroxidase or biotin that require stronger blocking steps. When a laboratory reports a marker as validated, ask which species and tissues were used for that validation. The MSD Veterinary Manual provides species-specific guidance on sample handling and diagnostic testing that can inform your protocol choices.

What records should I keep for IHC stains, and for how long?

Retain the accession number, tissue block, slide identifiers, antibody clone and lot number, dilution, retrieval method, detection system, and the pathologist's interpretation. Photographs of the stained slide are useful for teaching and for client communication, but they do not replace the physical slide. Keep the block and slides according to your jurisdiction's requirements for medical records, which may extend for years after the case is closed. If the stain is part of a regulatory or insurance claim, preserve the entire chain of custody. The AVMA practice resources outline record-keeping expectations for veterinary practices in the United States, and your regional veterinary board may impose additional rules.

How do I explain an inconclusive IHC result to a client or referring veterinarian?

State plainly that the stain did not produce a definitive answer, and explain the two most common reasons: the tissue may have been inadequately fixed or processed, or the antibody may not have bound as expected. Avoid implying that the test failed because of laboratory incompetence. Offer the next step, which may be repeating the stain on a fresh biopsy, trying a different antibody clone, or submitting the case to a veterinary pathologist for a second opinion. Provide the written report and note that the clinical picture remains the primary guide for treatment decisions. The Davis-Thompson Foundation veterinary pathology resources offer case material that can help you frame these discussions with owners.

When should I refer a case for a second opinion on IHC interpretation?

Refer when the result conflicts with the clinical presentation, when the stain is weak or patchy, when the differential diagnosis carries major therapeutic or prognostic consequences, or when the laboratory's interpretation is outside your comfort zone. A second opinion is also appropriate when the primary laboratory cannot run the required marker and you need a specialised panel. Send the original slides, blocks, and the full clinical history. Ask the consulting pathologist specifically whether the staining pattern is consistent with the suspected diagnosis and whether additional markers would clarify the case. For cases with regulatory or trade implications, consult the WOAH terrestrial animal health standards to confirm which diagnostic procedures are recognized for official purposes.

Related Clinical & Scientific Guides

• Hypersensitivity Reactions: Types and Mechanisms
• Therapeutic Decision-Making for Respiratory Infections in Cattle
• Monitoring Fluid Therapy in Critically Ill Veterinary Patients

References and Further Reading

• Davis-Thompson Foundation Veterinary Pathology Resources. Davis-Thompson Foundation.
• MSD Veterinary Manual, Professional Edition. MSD Veterinary Manual.
• American Veterinary Medical Association Practice Resources. American Veterinary Medical Association.
• WOAH Terrestrial Animal Health Code. WOAH.

Related Articles

• Vaccinology: Principles and Vaccine Types
• Monitoring Protocols for Chemotherapy in Veterinary Oncology Patients
• Serology and Molecular Diagnostics in Infectious Disease
• Acute Inflammation: Vascular and Cellular Events
• Adaptive Immunity: B Cell and T Cell Responses

This article is educational professional reference material for veterinary audiences. It is not a substitute for veterinary diagnosis, individual clinical judgment, current product labeling, or applicable regulatory requirements.